Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
MLH3 Gene Colorectal cancer, hereditary nonpolyposis type 7 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 26 |
|
Tempus Labs, Inc. United States | 2 | 647 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
MLH3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
PathGroup United States | 73 | 505 |
|
Ambry Genetics United States | 79 | 80 |
|
Endometrial cancer, susceptibility to, 608089 (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Colorectal cancer, hereditary nonpolyposis, type 7, 614385; HNPCC7 (Lynch syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Colorectal cancer, somatic, 114500 (MLH3 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PrimBio Colorectal Cancer Panel PrimBio Research Institute United States | 1 | 52 |
|
Ambry Genetics United States | 147 | 91 |
|
PreventionGenetics, part of Exact Sciences United States | 32 | 25 |
|
PreventionGenetics, part of Exact Sciences United States | 122 | 117 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.